Chancellor Rachel Reeves Plans Focused Action on Living Costs in Upcoming Budget

Treasury head Rachel Reeves has stated she is preparing "targeted steps to address household expense challenges" in next month's financial statement.

During an interview with media outlets, she noted that curbing inflation is a shared responsibility of both the administration and the Bank of England.

The UK's price growth is expected to be the most elevated among the G7 industrialized countries this year and next.

Possible Energy Bill Measures

Reports indicate the government could take action to lower utility costs, for instance by reducing the current 5% level of value-added tax charged on energy supplies.

A further possibility is to reduce some of the government charges presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The government will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for such actions.

The expectation from most economists is that the Chancellor will have to introduce higher taxes or budget cuts in order to meet her declared debt limits.

Previously on the same day, calculations showed there was a £22 billion deficit for the Treasury chief to address, which is at the lower end of expectations.

"It is a joint job between the Bank of England and the administration to continue tackling some of the drivers of inflation," Reeves informed reporters in the US capital, at the annual meetings of the IMF and World Bank.

Tax Commitments and International Issues

While a great deal of the attention has been on likely tax increases, the chancellor said the latest information from the OBR had not changed her pledge to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with rising international and trade issues for the Budget revenue measures, probably to be focused on those "most able to pay."

Global Economic Tensions

Referring to apprehensions about the United Kingdom's economic relations with China she said: "Our national security always are paramount."

Last week's statement by China to tighten export controls on rare earths and other resources that are crucial for advanced tech production led American leader Donald Trump to propose an extra 100% import tax on goods from China, raising the possibility of an all-out commercial conflict between the two largest economies.

The American finance chief called China's move "economic coercion" and "a international production power grab."

Inquired about considering the American proposal to participate in its dispute with China, Reeves said she was "very concerned" by Chinese actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the move was "damaging for the international commerce and causes further challenges."

"It is my opinion there are fields where we should address Chinese policies, but there are also important chances to export to Chinese markets, including banking sector and other sectors of the economy. We've got to maintain that equilibrium correct."

The Treasury chief also affirmed she was cooperating with G7 counterparts "on our own critical minerals strategy, so that we are reduced dependence."

NHS Drug Pricing and Investment

Reeves also recognized that the price the National Health Service pays for drugs could increase as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and investment.

A number of the world's largest pharmaceutical manufacturers have said lately that they are either halting or scrapping projects in the UK, with several attributing the modest returns they are obtaining.

Recently, the Science Minister said the price the NHS spends on drugs would need to rise to stop firms and drug research funding leaving the United Kingdom.

Reeves stated to the BBC: "It has been observed due to the payment system, that clinical trials, recent pharmaceuticals have not been offered in the United Kingdom in the way that they are in other European countries."

"We want to ensure that patients receiving care from the NHS are can obtain the finest critical treatments in the globe. And so we are looking at this situation, and... aiming to obtain increased capital into the UK."